Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4444379
Max Phase: Preclinical
Molecular Formula: C54H87N3O15
Molecular Weight: 1018.30
Molecule Type: Unknown
Associated Items:
ID: ALA4444379
Max Phase: Preclinical
Molecular Formula: C54H87N3O15
Molecular Weight: 1018.30
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N(C)C)[C@H]2O)[C@@H](CC(C(=O)NC(C)(C)C)N(C(=O)c2ccccc2)C(C)C)C[C@@H](C)C(=O)/C=C/C(C)=C/[C@@H]1CO[C@H]1O[C@@H](C)[C@H](O)[C@H](OC)[C@@H]1OC
Standard InChI: InChI=1S/C54H87N3O15/c1-16-41-37(28-68-53-49(67-15)48(66-14)45(62)34(8)70-53)24-30(4)22-23-39(58)31(5)25-36(26-38(50(64)55-54(9,10)11)57(29(2)3)51(65)35-20-18-17-19-21-35)47(32(6)40(59)27-42(60)71-41)72-52-46(63)43(56(12)13)44(61)33(7)69-52/h17-24,29,31-34,36-38,40-41,43-49,52-53,59,61-63H,16,25-28H2,1-15H3,(H,55,64)/b23-22+,30-24+/t31-,32+,33-,34+,36-,37-,38?,40-,41-,43+,44-,45+,46-,47-,48+,49+,52+,53+/m1/s1
Standard InChI Key: ROZSTEFVCGZWOV-LPAVKCALSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1018.30 | Molecular Weight (Monoisotopic): 1017.6137 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Budragchaa T, Westermann B, Wessjohann LA.. (2019) Multicomponent synthesis of α-acylamino and α-acyloxy amide derivatives of desmycosin and their activity against gram-negative bacteria., 27 (15): [PMID:31229422] [10.1016/j.bmc.2019.05.046] |
Source(1):